Bristol Myers Squibb – What’s Left After Clopidogrel?
Over the past year, some of my writing has focused on the pipelines of many big pharmaceutical players, including GSK, JNJ, ABT, MRK, LLY, SNY, NVS, FRX and PFE. I noted that the patent cliff is going to be steep in my PFE...
Read More

